StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)

Close on Nov 17, 2026Market cap $150.87MP/E –Yield –

Earnings

Inogen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$95.10M
+3.0% on a year earlier
Adjusted EPS, Q2 FY2026
-$0.14
-$0.02 a year earlier
Latest guidance
Lowered
Aug 6, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Inogen's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close––––Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026during market hours$95.10M+3.0%-$0.14–Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours$85.10M+3.4%-$0.30-$0.14Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026during market hours$81.70M+2.0%-$0.26-$0.15Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open$92.40M+4.1%-$0.20-$0.02Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025during market hours$92.30M+3.9%-$0.15-$0.02Release
Q1 FY2025ended Mar 31, 2025May 7, 2025during market hours$82.30M+5.5%-$0.25–Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025during market hours$80.10M+5.5%-$0.41-$0.24Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024during market hours$88.80M+5.7%-$0.25-$0.11Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024during market hours$88.80M+6.2%-$0.24-$0.07Release
Q1 FY2024ended Mar 31, 2024May 7, 2024during market hours$78.00M+8.0%-$0.62-$0.45Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Inogen's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
reported revenueFY2026$355.00M – $361.00M$366.00M – $373.00MLoweredAug 6, 2026
reported revenueGAAPFY2026$366.00M – $373.00M–NewFeb 24, 2026
adjusted EBITDAnon-GAAPFY2026$4.00M–NewAug 6, 2026

Guidance vs results

The last range Inogen gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q2 FY2026Revenue$94.00M – $97.00M$95.10MWithin range
FY2025Revenue$354.00M – $357.00M$348.70MΣ4QBelow range
Q4 FY2025Revenue$87.00M – $90.00M$81.70MBelow range
Q3 FY2025Revenue$91.00M – $93.00M$92.40MWithin range
Q2 FY2025Revenue$89.00M – $91.00M$92.30MAbove range
Q1 FY2025Revenue$79.00M – $81.00M$82.30MAbove range
Q2 FY2024Revenue$81.00M – $84.00M$88.80MAbove range
Q1 FY2024Revenue$73.00M – $74.00M$78.00MAbove range
Q4 FY2022Revenue$87.00M – $92.00M$88.10MWithin range
Q3 FY2022Revenue$97.00M – $100.00M$105.40MAbove range

Guidance history

Every forecast Inogen put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 6, 2026adjusted EBITDAFY2026$4.00MNew
Aug 6, 2026reported revenueFY2026$355.00M – $361.00MLowered
May 7, 2026reported revenueFY2026$366.00M – $373.00MNew
May 7, 2026reported revenueQ2 FY2026$94.00M – $97.00MNew
Feb 24, 2026reported revenueFY2026$366.00M – $373.00MNew
Nov 5, 2025Adjusted EBITDAFY2025$2.00MNew
Nov 5, 2025reported revenueFY2025$354.00M – $357.00MNew
Nov 5, 2025reported revenueQ4 FY2025$87.00M – $90.00MNew
Aug 7, 2025reported revenueQ3 FY2025$91.00M – $93.00MNew
Aug 7, 2025reported revenueFY2025$354.00M – $357.00MRaised
May 7, 2025reported revenueQ2 FY2025$89.00M – $91.00MNew
May 7, 2025revenue growth relative to the Company’s 2024 revenueFY2025+5% – +6%New
May 7, 2025reported revenueFY2025$352.00M – $355.00MReaffirmed
Feb 25, 2025gross marginFY202543% – 45%New
Feb 25, 2025revenueQ1 FY2025$79.00M – $81.00MNew
Feb 25, 2025revenueFY2025$352.00M – $355.00MNew
Nov 7, 2024revenue growthFY2024+4% – +5%New
Nov 7, 2024revenueFY2024$329.00M – $331.00MRaised
Aug 6, 2024revenueFY2024$325.00M – $330.00MNew
May 7, 2024revenueQ2 FY2024$81.00M – $84.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Inogen filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Update
  6. Results
  7. Update
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?